We use cookies to ensure you get the best experience on adphealth.org. We also collect and share information about the use of the website. View our privacy policy

Accept
EN JP

Access and Delivery Partnership: TB, malaria and NTD health technologies for those in need

Impact stories

English Japanese

01 A decade of partnership

Since 2013, in partnership with the Government of Japan, the United Nations Development Programme (UNDP) has worked to strengthen policies, institutions, systems and capacities to increase people’s access to life-saving health technologies—vaccines, medicines and diagnostic tools for tuberculosis (TB), malaria and neglected tropical diseases (NTDs)—diseases that disproportionately affect the poor.

The strategic approach of the UNDP-led Access and Delivery Partnership (ADP) is informed by two key lessons. First, even where innovative health technologies are developed, their introduction and use within national health systems are often constrained by country-specific bottlenecks and challenges. ADP focuses on identifying and strengthening the relevant human, technical and institutional capacities to address these challenges. Second, successful introduction and delivery of new health technologies also depends on coordination and coherence of domestic institutions. For this reason, ADP supports countries to strengthen policies and systems that drive country-led changes for sustainable and multisectoral approaches. Together, strengthened capacities with a coordinated multisectoral approach will enable sustained improvements in access to health and enhance progress towards universal health coverage (UHC), pandemic preparedness and human security.

Working with national, regional and global stakeholders, the core partners of ADP—UNDP, the World Health Organization (WHO), the Special Programme for Research and Training in Tropical Diseases (TDR) and PATH—have delivered results.

This report shares a collection of stories that put a spotlight on the impact that ADP is having on people’s lives. These stories underscore the importance of the partnership between UNDP and the Government of Japan. This partnership strives towards a common goal, one that is reflected in the 2030 Agenda for Sustainable Development, the UNDP Strategic Plan 2022-2025 and in Japan’s new Global Health Strategy: that of building resilience of national health systems and prioritizing universal health coverage as an important means towards achieving human security.

ADP core partner organizations

The four ADP partners each bring a unique set of expertise to the partnership, helping identify and strengthen capacity gaps in low- and middle-income countries (LMICs) in innovative and integrated ways.

UNDP is the leading United Nations organization fighting to end the injustice of poverty, inequality and climate change through its broad network of experts and partners in 170 countries. As the lead agency for ADP, UNDP manages and coordinates the partnership. UNDP supports the ADP focus countries on the development and introduction of national policy and legal and governance frameworks, and facilitates the digital transformation of health systems. UNDP also aids the establishment of multisectoral forums across government agencies and leads ADP’s strategic focus on South–South learning and exchange.
WHO is the directing and coordinating authority on international health within the United Nations system, working with 194 Member States in a shared commitment to achieve better health for everyone, everywhere. WHO supports the benchmarking of national regulatory authorities in ADP focus countries, promoting regulatory harmonization by addressing capacity gaps and facilitating coalition-focused approaches. Within ADP, WHO also helps strengthen processes for market surveillance and quality monitoring of health technologies.
TDR is a global programme of scientific collaboration that helps facilitate, support and influence efforts to combat diseases of poverty. It is co-sponsored by the United Nations Children’s Fund (UNICEF), UNDP, the World Bank and WHO. Within ADP, TDR focuses on pharmacovigilance systems, including strengthening capacities for safety monitoring of new health technologies and related surveillance, reporting and data management capacities. TDR also supports national research institutions, disease control programmes and health researchers to systematically apply implementation research principles towards effective introduction and use of new health technologies.
PATH is an international non-governmental organization that drives transformative innovation to save lives and improve health, especially for women and children. Working with ADP focus countries, PATH supports sustainable evidence-based resource allocation processes, enabling LMICs to evaluate the implications of the introduction of new health technologies. Areas of focused technical support include institutionalizing priority-setting strategies as tools for informed health decision-making, and strategic approaches to ‘value-based’ planning, procurement and supply chain management.
ADP covers nine ‘focus’ countries and has reached over 60 countries through its South–South learning and exchange.
Share on